The CSM(B) discussed the possibility of withdrawing US preparations. It was concluded that this was not feasible on the grounds of supply. Moreover, the perceived level of risk did not "at present justify serious consideration of such a solution".
Chronology Information
Date:
Chapter/issue
Blood Products and Addressing Risk: Regulation of Commercial Factor Concentrates